Login Register Cart 0
Generic placeholder image

Coronaviruses

Editor-in-Chief

ISSN (Print): 2666-7967
ISSN (Online): 2666-7975

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Research Article

Ultrastructural Blood Cell Changes in Patients with COVID-19

Author(s): Yulian Kyyak, Olga Barnett, Marta Halkevych, Olha Labinska and Orysia Kysil*

Volume 4, Issue 3, 2023

Published on: 05 October, 2023

Article ID: e051023221751 Pages: 7

DOI: 10.2174/0126667975265782230925055259

Price: $65

Abstract

Introduction: Nowadays, the coronavirus disease COVID-19 is a global problem for the population of the whole world which has acquired the character of a pandemic. Under physiological conditions, in a healthy person, erythrocytes make up 96% of all blood cells, leukocytes 3%, and thrombocytes about 1%. In healthy individuals, erythrocytes are mostly shaped like a biconcave disc and do not contain a nucleus. The diameter of the erythrocyte is 8 microns, but the peculiarities of the cell structure and the membrane structure ensure their great ability to deform and pass through capillaries with a narrow lumen of 2-3 microns. Therefore, the study of the morpho-functional state of blood cells, namely erythrocytes, in this category of patients is relevant and deserves further research.

The Aim: To figure out the effect of the coronavirus disease COVID-19 on the ultrastructural blood cell changes, in particular erythrocytes, in patients with ischemic heart disease (IHD) and diabetes mellitus type 2.

Materials and Methods: Twelve patients with COVID-19 who had an acute myocardial infarction were examined. The comparison group consisted of 10 people with acute myocardial infarction without symptoms of COVID-19. The average age of the patients was 62 ± 5,6 years. The functional state and ultrastructure of blood cells were studied using electron microscopy.

Results: In the presence of COVID-19, we detected both calcification and destruction of erythrocytes and platelets. Reticulocytes were detected much more often in these individuals than in the comparison group. In patients with acute myocardial infarction in the presence of type 2 diabetes and COVID-19, a significant number of markedly deformed, hemolyzed erythrocytes or with signs of acanthosis, which stuck together and with other destructively changed blood cells, were found. We also detected «neutrophils extracellular traps» (NETs).

Conclusions: Morphological changes of blood cells in COVID-19 varied according to the disease course and severity especially in the background of a weakened immune system in older and elderly people, in the presence of diabetes, excessive body weight, cardiovascular diseases and occupational hazards. Under the influence of COVID-19, blood cells are destroyed by apoptosis and necrosis. Therefore, hypoxia and ischemia of vital organs of the human body occur.

Graphical Abstract

[1]
Prodanchuk MG, Balan GM, Kurdil NV, Zhminko PG, Bubalo NM, Dyachuk DD, et al. Toxicologist`s opinion on the mechanisms of virus-induced hemoglobinopathies with toxic pneumonitis and systemic hypoxemia from COVID-19and substantiation of rationaldetoxification methods. Ukrain J mod prob toxicol 2020; 1: 23-41.
[2]
Casey K, Iteen A, Nicolini R, Auten J. COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection. Am J Emerg Med 2020; 38(7): 1544.e1-3.
[http://dx.doi.org/10.1016/j.ajem.2020.04.011] [PMID: 32312574]
[3]
Bennett TD, Hayward KN, Farris RWD, Ringold S, Wallace CA, Brogan TV. Very high serum ferritin levels are associated with increased mortality and critical care in pediatric patients. Pediatr Crit Care Med 2011; 12(6): e233-6.
[http://dx.doi.org/10.1097/PCC.0b013e31820abca8] [PMID: 21263363]
[4]
Tonial CT, Garcia PCR, Schweitzer LC, et al. Cardiac dysfunction and ferritin as early markers of severity in pediatric sepsis. J Pediatr 2017; 93(3): 301-7.
[http://dx.doi.org/10.1016/j.jped.2016.08.006] [PMID: 28126563]
[5]
Castillo L, Carcillo J. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med 2009; 10(3): 387-92.
[http://dx.doi.org/10.1097/PCC.0b013e3181a1ae08] [PMID: 19325510]
[6]
Rosário C, Zandman-Goddard G, Meyron-Holtz EG, D’Cruz DP, Shoenfeld Y. The hyperferritinemic syndrome: Macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med 2013; 11(1): 185.
[http://dx.doi.org/10.1186/1741-7015-11-185] [PMID: 23968282]
[7]
Lippi G, Mattiuzzi C. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematol Transfus Cell Ther 2020; 42(2): 116-7.
[http://dx.doi.org/10.1016/j.htct.2020.03.001] [PMID: 32284281]
[8]
Wynants L, Van Calster B, Bonten MM, Collins GS, Debray TA, De Vos M, et al. Prediction models for diagnosis and prognosis of covid-19 infection: Systematicreview and critical appraisal. BMJ 2020; 369: 1328.
[http://dx.doi.org/10.1101/2020.03.24.20041020]
[9]
Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol 2020; 95(7): 834-47.
[http://dx.doi.org/10.1002/ajh.25829] [PMID: 32282949]
[10]
Fan BE, Chong VCL, Chan SSW, et al. Hematologic parameters in patients with COVID‐19 infection. Am J Hematol 2020; 95(6): E131-4.
[http://dx.doi.org/10.1002/ajh.25774] [PMID: 32129508]
[11]
Chng WJ, Lai HC, Earnest A, Kuperan P. Haematological parameters in severe acute respiratory syndrome. Clin Lab Haematol 2005; 27(1): 15-20.
[http://dx.doi.org/10.1111/j.1365-2257.2004.00652.x] [PMID: 15686503]
[12]
Liu W, Li H. COVID-19: Attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit humanheme metabolism. electronic resource. URI chemrxiv Available from :https://chemrxiv.org/ndownloader/files/22283226
[13]
Perlman S. Another decade, another coronavirus. N Engl J Med 2020; 382(8): 760-2.
[http://dx.doi.org/10.1056/NEJMe2001126] [PMID: 31978944]
[14]
Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020; 395(10223): 470-3.
[http://dx.doi.org/10.1016/S0140-6736(20)30185-9] [PMID: 31986257]
[15]
WHO. Coronavirus disease 2019 (COVID-19). Situation Report –57. 2020. Available from: https://www.who.int/docs/default source/coronaviruse/situation-reports/20200317-sitrep-57-covid-19.pdf?sfvrsn=a26922f2_4
[16]
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in china, 2019. N Engl J Med 2020; 382(8): 727-33.
[http://dx.doi.org/10.1056/NEJMoa2001017] [PMID: 31978945]
[17]
Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from wuhan: An analysis based on decade-long structural studies of SARS coronavirus. J Virol 2020; 94(7): e00127-20.
[http://dx.doi.org/10.1128/JVI.00127-20] [PMID: 31996437]
[18]
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020; 395(10223): 507-13.
[http://dx.doi.org/10.1016/S0140-6736(20)30211-7] [PMID: 32007143]
[19]
Morse JS, Lalonde T, Xu S, Liu WR. Learning from the Past: Possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019‐nCoV. ChemBioChem 2020; 21(5): 730-8.
[http://dx.doi.org/10.1002/cbic.202000047] [PMID: 32022370]
[20]
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798): 270-3.
[http://dx.doi.org/10.1038/s41586-020-2012-7] [PMID: 32015507]
[21]
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]
[22]
Guan W, Ni Z, Hu Y, et al. Clinical characteristics ofcoronavirus disease 2019 in China. N Engl J Med 2020; 382(18): 1708-20.
[http://dx.doi.org/10.1056/NEJMoa2002032] [PMID: 32109013]
[23]
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med 2020; 8(5): 475-81.
[http://dx.doi.org/10.1016/S2213-2600(20)30079-5] [PMID: 32105632]
[24]
Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic features and clinical course of patientsinfected with SARS-CoV-2 in Singapore. JAMA 2020; 323(15): 1488-94.
[http://dx.doi.org/10.1001/jama.2020.3204] [PMID: 32125362]
[25]
Reade MC, Weissfeld L, Angus DC, Kellum JA, Milbrandt EB. The prevalence of anemia and its association with 90-day mortality in hospitalized community-acquired pneumonia. BMC Pulm Med 2010; 10(1): 15.
[http://dx.doi.org/10.1186/1471-2466-10-15] [PMID: 20233445]
[26]
Wang F, Hou H, Luo Y, et al. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight 2020; 5(10): e137799.
[http://dx.doi.org/10.1172/jci.insight.137799] [PMID: 32324595]
[27]
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 2020; 137244.
[http://dx.doi.org/10.1172/JCI137244]
[28]
Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol 2020; 75(23): 2950-73.
[http://dx.doi.org/10.1016/j.jacc.2020.04.031] [PMID: 32311448]
[29]
Reynolds ES. The use of lead citrate at high ph as an electron-opaque stain in electron microscopy. J Cell Biol 1963; 17(1): 208-12.
[http://dx.doi.org/10.1083/jcb.17.1.208] [PMID: 13986422]
[30]
Color Atlas of Microscopic Anatomy. Frihjof Hammersen M. D. Munich 1985.
[31]
Kyyak YuH, Kohut MA, Andrushevska OYu, Kohut LM, Kyyak HYu, Barnett OY. Calcification and apoptosis of blood cells as a marker of the presence, severity and progression of coronary heart disease associated with type 2 diabetes mellitus: ultrastructural and cytological studies. Int J Endocrinol 2016; 4: 15-21.
[32]
Pandey AK, Blaha MJ, Sharma K, et al. Family history of coronary heart disease and the incidence and progression of coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2014; 232(2): 369-76.
[http://dx.doi.org/10.1016/j.atherosclerosis.2013.11.042] [PMID: 24468150]
[33]
Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010; 303(16): 1610-6.
[http://dx.doi.org/10.1001/jama.2010.461] [PMID: 20424251]
[34]
Quintanar-Escorza MA, González-Martínez MT, del Pilar IOM, Calderón-Salinas JV. Oxidative damage increases intracellular free calcium [Ca2+]i concentration in human erythrocytes incubated with lead. Toxicol In Vitro 2010; 24(5): 1338-46.
[http://dx.doi.org/10.1016/j.tiv.2010.05.002] [PMID: 20460147]
[35]
Shen L, Chen L, Chi H, et al. Parameters and morphological changes of erythrocytes and platelets of covid-19 subjects: A longitudinal cohort study. Infect Drug Resist 2023; 16: 1657-68.
[http://dx.doi.org/10.2147/IDR.S400735] [PMID: 36992967]
[36]
Nykonenko AS, Nykonenko AA, Gavrilenko BS, Lozovoi AI. 64-multyslice computed tomography: Detection of coronary artery disease in patients with ischemic heart disease. Zaporozhye med J 2015; 1(88): 4-8.
[37]
Kolesnik NV, Kachanova ZS. Biology of neutrophils, a modern view. The review. BulletZaporizh Nat Univ 2009; 1: 80-91.
[38]
Gomolyako VI, Nikulnikov PI, Liksunov OV, Dubovich TO, Klochkova NE, Ratushnyuk AV. State of neutrophil granulocytes systemas a risk factor for post surgery complications in abdominal aortic aneurysm. UMJ. Heart Vessels 2015; 3: 80-5.
[39]
Sapino A, Facchetti F, Bonoldi E, Gianatti A, Barbareschi M. The autopsy debate during the COVID-19 emergency: The Italian experience. Virchows Arch 2020; 476(6): 821-3.
[http://dx.doi.org/10.1007/s00428-020-02828-2] [PMID: 32350596]
[40]
Tian S, Xiong Y, Liu H, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol 2020; 33(6): 1007-14.
[http://dx.doi.org/10.1038/s41379-020-0536-x] [PMID: 32291399]
[41]
Farkas CB, Petrétei D, Babinszky G, et al. Role of duties related to COVID-19 suspected, probable and confirmed fatality cases. Orv Hetil 2020; 161(17): 713-22.
[http://dx.doi.org/10.1556/650.2020.31818] [PMID: 32324985]
[42]
Lichtenberger LM, Szabo S. A closer look at endothelial injury-induced platelet hyperactivity and the use of aspirin in the treatment of COVID infection. Inflammopharmacology 2022; 30(4): 1475-6.
[http://dx.doi.org/10.1007/s10787-022-01015-w] [PMID: 35729443]
[43]
Rampotas A, Pavord S. Platelet aggregates, a marker of severe COVID-19 disease. J Clin Pathol 2021; 74(11): 750-1.
[http://dx.doi.org/10.1136/jclinpath-2020-206933] [PMID: 33067181]
[44]
Zuo Y, Yalavarthi S, Shi H, et al. Neutrophil extracellular traps in COVID-19. JCI Insight 2020; 5(11): e138999.
[http://dx.doi.org/10.1172/jci.insight.138999] [PMID: 32329756]
[45]
Pedersen SF, Ho YC. SARS-CoV-2: A storm is raging. J Clin Invest 2020; 130(5): 2202-5.
[http://dx.doi.org/10.1172/JCI137647] [PMID: 32217834]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy